<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03985059</url>
  </required_header>
  <id_info>
    <org_study_id>MMI_2018_12</org_study_id>
    <nct_id>NCT03985059</nct_id>
  </id_info>
  <brief_title>Impact of Verticalization on Intracranial Hemodynamics Assessed in Transcranial Doppler at the Acute Phase of Cerebral Infarction</brief_title>
  <acronym>STAND</acronym>
  <official_title>Impact of Verticalization on Intracranial Hemodynamics Assessed in Transcranial Doppler at the Acute Phase of Cerebral Infarction (STAND : iSchemic sTroke evAluated at Bed Side With ultrasouND)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Fondation Ophtalmologique Adolphe de Rothschild</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Fondation Ophtalmologique Adolphe de Rothschild</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The management of patients with ischemic stroke or transient ischemic attack is based on the&#xD;
      preservation of a brain area by maintaining sufficient intracranial hemodynamics (IH) and&#xD;
      with rapid recanalization.&#xD;
&#xD;
      The impact of the patient's position (supine or seated position) on the IH in the event of&#xD;
      narrowing or occlusion of an artery is poorly assessed but may be of particular importance.&#xD;
      Variations in blood flow according to the positioning of the patient's body are measurable&#xD;
      using a transcranial Doppler.&#xD;
&#xD;
      The main objective is to verify whether intracerebral hemodynamic changes during early&#xD;
      verticalization after ischemic stroke or transient ischemic attack are more frequent in&#xD;
      patients with carotid stenosis or occlusion compared to those without stenosis or occlusion.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    no need to include more patients for analysis. 40 patients initially (36 actual)&#xD;
  </why_stopped>
  <start_date type="Actual">November 15, 2019</start_date>
  <completion_date type="Actual">February 15, 2021</completion_date>
  <primary_completion_date type="Actual">February 15, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Percentage of patients with a change in mean cerebral artery velocity (MCAVM) in transcranial Doppler</measure>
    <time_frame>2 minutes</time_frame>
    <description>Percentage of patients with a change in mean cerebral artery velocity (MCAVM) in transcranial Doppler (defined by a variation of more than 10%) on the symptomatic side evaluated in transcranial Doppler when changing from the lying position (0°) to the 90° position (measured 2 minutes after verticalization).</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">36</enrollment>
  <condition>Stroke</condition>
  <arm_group>
    <arm_group_label>Cases</arm_group_label>
    <description>Patients with ischemic stroke or transient ischemic attack who have carotid stenosis greater than 50% NASCET (North American Symptomatic Carotid Endarterectomy Trial) or an occlusion.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Controls</arm_group_label>
    <description>Patients with ischemic stroke or transient ischemic attack who do not have carotid stenosis greater than 50% NASCET (North American Symptomatic Carotid Endarterectomy Trial) or an occlusion.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Transcranial Doppler</intervention_name>
    <description>Initially, the patient will be placed in a strict supine position (at 0°) in his hospital bed in the USINV, according to the usual care. In a second step, the patient will be verticalized (from 0° to 90°). HI parameters in supine position and during verticalization will be recorded continuously by placing the transcranial Doppler helmet.&#xD;
After 15 minutes of recording, the patient will be placed back in supine position. The end of the patient's participation in the study will correspond to the removal of the helmet.</description>
    <arm_group_label>Cases</arm_group_label>
    <arm_group_label>Controls</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Participants will be recruited during their hospitalization in the USINV for the management&#xD;
        of ischemic stroke.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Ischemic stroke (AIC) or transient ischemic attack (AIT) of the carotid artery&#xD;
&#xD;
          -  Duration of symptoms less than 48 hours&#xD;
&#xD;
          -  Absence of homolateral or downstream intracranial stenosis or occlusion M1&#xD;
&#xD;
          -  Lifting authorized by the referent clinician.&#xD;
&#xD;
          -  Rankin's score before AIC/AIT ≤ 2&#xD;
&#xD;
             • For cases:&#xD;
&#xD;
          -  Carotid stenosis of more than 50% NASCET (North American Symptomatic Carotid&#xD;
             Endarterectomy Trial) or an occlusion&#xD;
&#xD;
             • For controls:&#xD;
&#xD;
          -  Absence of carotid stenosis greater than 50% NASCET (North American Symptomatic&#xD;
             Carotid Endarterectomy Trial) or occlusion&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        - Disrupted vigilance&#xD;
&#xD;
        Secondary exclusion criteria:&#xD;
&#xD;
          -  Absence of a homolateral temporal acoustic window at the lesion&#xD;
&#xD;
          -  Impossibility to verticalize the patient&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Fondation Ophtalmique Adolphe de Rothschild</name>
      <address>
        <city>Paris</city>
        <zip>75019</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>March 2021</verification_date>
  <study_first_submitted>June 11, 2019</study_first_submitted>
  <study_first_submitted_qc>June 11, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">June 13, 2019</study_first_posted>
  <last_update_submitted>March 26, 2021</last_update_submitted>
  <last_update_submitted_qc>March 26, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">March 30, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Verticalization</keyword>
  <keyword>Doppler</keyword>
  <keyword>Intracranial hemodynamic</keyword>
  <keyword>Cerebral artery velocity</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cerebral Infarction</mesh_term>
    <mesh_term>Infarction</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

